Pharmacology

Cardiorenal Benefits for Ramipril and Rosiglitazone in IGT and IGF?

Fed Pract. 2008 October;25(10):25
PDF Download

 

Recommended Reading

Preventing Diabetes in Urban Native Americans
Federal Practitioner
Targeting BP and LDL in Patients with Diabetes: How Low to Go?
Federal Practitioner
Early Intervention for Diabetes-Related Renal Disease: Don't Let Rising Creatine Block the Way
Federal Practitioner
Use of Laser Doppler Imaging to Assess Microvascular Response to Thermal Stress
Federal Practitioner
ACS in Women with Diabetes—Sparse Data, Atypical Presentation
Federal Practitioner
Goal Attainment in Patients with Type 2 Diabetes, Part 1
Federal Practitioner
Rosiglitazone and Broken Bones
Federal Practitioner
Goal Attainment in Patients with Type 2 Diabetes, Part 2
Federal Practitioner
We Know Less than We Think
Federal Practitioner
Are Drug-Eluting Stents Safe in Patients with Diabetes?
Federal Practitioner